NRIX logo

Nurix Therapeutics (NRIX)

Profile

Full Name

Nurix Therapeutics, Inc.

Ticker Symbol

NRIX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 24, 2020

Indexes

Not included

Website

http://www.nurixtx.com

Employees

286

Key Details

Price

$10.51

Market Cap

$797.57M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$54.55M(-29.15% YoY)

Annual EPS

-$2.88(-8.68% YoY)

PE Ratio

-

Next earnings date

Apr 10, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$10.51
NRIX price is $10.51

Price All-time High

$50.17
NRIX price is currently -79.05% below its historical high of $50.17

Price Most Recent Change

-5.82%
NRIX price was down -5.82% on Apr 3, 2025

Price YTD Change

-44.21%
NRIX price is down -44.21% since January 1st

Price 1-year Change

-26.5%
NRIX price is down -26.5% year-on-year

Price 3-year Change

-24.66%
NRIX price is down -24.66% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$797.57M
NRIX market capitalization is $797.57 million

Market Cap 3-year Change

+27.19%
NRIX market capitalization is up +27.19% over the past 3 years

Market Cap All-time High

$2.04B
NRIX market capitalization is currently -60.84% below its historical high of $2.04 billion

Market Cap Sector Rank

74.24%
NRIX market capitalization is higher than 74.24% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+54.4%
NRIX shares outstanding is up +54.4% year-on-year

Shares Outstanding 3-Year Change

+68.82%
NRIX shares outstanding is up +68.82% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.85
NRIX beta is 1.85

200-day SMA

$20.66
NRIX price is currently -49.14% below its 200-day simple moving average

50-day SMA

$15.70
NRIX price is currently -33.07% below its 50-day simple moving average

RSI

29.09
NRIX 14-day relative strength index is 29.09

Volume

0.85
NRIX 30-day relative volume is 0.85

ATR

$0.88
NRIX average true range is $0.88

10-day Historical Volatility

92.66%
NRIX 10-day historical volatility is 92.66%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$54.55M
NRIX annual revenue is $54.55 million

Revenue Analysts Estimate

$54.95M
NRIX annual revenue is currently -0.73% lower than the consensus analysts' forecast

Revenue 1-year Change

-29.15%
NRIX annual revenue is down -29.15% year-on-year

Revenue Sector Rank

50.11%
NRIX annual revenue is higher than 50.11% of companies in Healthcare sector

EPS

EPS

-$2.88
NRIX annual earnings per share is -$2.88

EPS Analysts Estimate

-$3.14
NRIX annual earnings per share is currently -8.40% lower than the consensus analysts' forecast

EPS 1-year Change

-8.68%
NRIX annual earnings per share is down -8.68% year-on-year

EPS Sector Rank

30.65%
NRIX annual earnings per share is higher than 30.65% of companies in Healthcare sector

Profit

Gross Profit

-
NRIX annual gross profit value is unknown

Gross Margin

-
NRIX annual gross profit margin value is unknown

Operating Profit

-$213.03M
NRIX annual operating income is -$213.03 million

Operating Margin

-390.52%
NRIX annual operating profit margin is -390.52%

Net Income

-$193.57M
NRIX annual net profit is -$193.57 million

Net Margin

-354.85%
NRIX annual net profit margin is -354.85%

Expenses

Total Expenses

$267.58M
NRIX annual total expenses is $267.58 million

Operating Expenses

$267.58M
NRIX annual total operating expenses is $267.58 million

Cost Of Goods Sold

-
NRIX annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$45.94M
NRIX annual SGA is $45.94 million

Depreciation And Amortization

$16.43M
NRIX annual depreciation & amortization is $16.43 million

Interest Expense

-
NRIX annual interest expense value is unknown

Income Tax

$270.00K
NRIX annual income tax is $270.00 thousand

EBIT & EBITDA

EBIT

-$213.03M
NRIX annual earnings before interest & taxes is -$213.03 million

EBITDA

-$196.60M
NRIX annual EBITDA is -$196.60 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$669.34M
NRIX annual total assets is $669.34 million

Non Current Assets

$49.96M
NRIX annual long term assets is $49.96 million

Current Assets

$619.39M
NRIX annual total current assets is $619.39 million

Cash And Cash Equivalents

$110.00M
NRIX annual cash & cash equivalents is $110.00 million

Accounts Receivable

-
NRIX annual accounts receivable value is unknown

Inventory

-
NRIX annual inventory value is unknown

Liabilities

Total Liabilities

$142.35M
NRIX annual total liabilities is $142.35 million

Long Term Liabilities

$46.50M
NRIX annual total long term liabilities is $46.50 million

Current Liabilities

$95.85M
NRIX annual total current liabilities is $95.85 million

Accounts Payable

$11.48M
NRIX annual accounts payable is $11.48 million

Debt

Total Debt

$28.30M
NRIX annual total debt is $28.30 million

Total Debt 1-year Change

-7.55%
NRIX annual total debt is down -7.55% year-on-year

Long Term Debt

$20.29M
NRIX annual long term debt is $20.29 million

Short Term Debt

$8.01M
NRIX annual short term debt is $8.01 million

Equity & Capital

Shareholders Equity

$526.99M
NRIX annual stockholders equity is $526.99 million

Book Value

$526.99M
NRIX annual book value is $526.99 million

Retained Earnings

-$738.77M
NRIX annual retained earnings is -$738.77 million

Working Capital

$523.53M
NRIX annual working capital is $523.53 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$172.58M
NRIX annual cash flow from operations is -$172.58 million

Cash From Operations 1-year Change

-112.11%
NRIX annual cash flow from operations is down -112.11% year-on-year

Cash From Investing

-$257.71M
NRIX annual cash flow from investing activities is -$257.71 million

Cash From Investing 1-year Change

-477.32%
NRIX annual cash flow from investing activities is down -477.32% year-on-year

Cash From Financing

$485.67M
NRIX annual cash flow from financing activities is $485.67 million

Cash From Financing 1-year Change

+14996.89%
NRIX annual cash flow from financing activities is up +14996.89% year-on-year

CAPEX

CAPEX

$9.27M
NRIX annual capital expenditures is $9.27 million

CAPEX 1-year Change

+10.38%
NRIX annual capital expenditures is up +10.38% year-on-year

Free Cash Flow

Free Cash Flow

-$181.86M
NRIX annual free cash flow is -$181.86 million

Free Cash Flow 1-year Change

-102.59%
NRIX annual free cash flow is down -102.59% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
NRIX annual gross profit margin value is unknown

Operating Margin

-390.52%
NRIX annual operating profit margin is -390.52%

Net Margin

-354.85%
NRIX annual net profit margin is -354.85%

ROA & ROE

ROA

-37.77%
NRIX annual return on assets is -37.77%

ROE

-53.22%
NRIX annual return on equity is -53.22%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
NRIX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
NRIX price to earnings ratio is unknown

PB Ratio

PB Ratio

1.51
NRIX price to book ratio is 1.51

PB Ratio Sector Rank

54.84%
NRIX price to book ratio is higher than 54.84% of companies in Healthcare sector

PS Ratio

PS Ratio

14.62
NRIX price to sales ratio is 14.62

PS Ratio Sector Rank

83.61%
NRIX price to sales ratio is higher than 83.61% of companies in Healthcare sector

Enterprise value

Enterprise Value

$715.88M
NRIX enterprise value is $715.88 million

Enterprise Value Sector Rank

72.16%
NRIX enterprise value is higher than 72.16% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.64
NRIX EV/EBITDA is -3.64

EV/EBITDA Sector Rank

23.23%
NRIX EV/EBITDA is higher than 23.23% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

6.46
NRIX annual current ratio is 6.46

Quick Ratio

-
NRIX annual quick ratio value is unknown

Leverage

Debt To Equity

0.00
NRIX annual debt to equity ratio is 0.00

Interest Coverage Ratio

-
NRIX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
NRIX piotroski f-score value is unknown

Altman Z-Score

1.79
NRIX altman z-score is 1.79

Analyst ratings

Recent major analysts updates

Apr 2, 25 HC Wainwright & Co.
Buy
Mar 17, 25 Leerink Partners
Market Perform
Feb 3, 25 Morgan Stanley
Equal-Weight
Jan 29, 25 Stifel
Buy
Jan 29, 25 RBC Capital
Outperform
Jan 29, 25 Needham
Buy
Jan 29, 25 JP Morgan
Overweight
Jan 29, 25 HC Wainwright & Co.
Buy
Jan 21, 25 Stephens & Co.
Overweight
Dec 11, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

CMRX logo
Chimerix (CMRX)
DNTH logo
Dianthus Therapeutics (DNTH)
PHVS logo
Pharvaris NV (PHVS)
RCUS logo
Arcus Biosciences (RCUS)
PAHC logo
Phibro Animal Health (PAHC)
VIR logo
Vir Biotechnology (VIR)
AXGN logo
AxoGen (AXGN)
DAWN logo
Day One Biopharmaceuticals (DAWN)
AMN logo
AMN Healthcare Services (AMN)
  • What is the ticker symbol for Nurix Therapeutics?
  • Does Nurix Therapeutics pay dividends?
  • What sector is Nurix Therapeutics in?
  • What industry is Nurix Therapeutics in?
  • What country is Nurix Therapeutics based in?
  • When did Nurix Therapeutics go public?
  • Is Nurix Therapeutics in the S&P 500?
  • Is Nurix Therapeutics in the NASDAQ 100?
  • Is Nurix Therapeutics in the Dow Jones?
  • When was Nurix Therapeutics's last earnings report?
  • When does Nurix Therapeutics report earnings?
  • Should I buy Nurix Therapeutics stock now?

What is the ticker symbol for Nurix Therapeutics?

The ticker symbol for Nurix Therapeutics is NASDAQ:NRIX

Does Nurix Therapeutics pay dividends?

No, Nurix Therapeutics does not pay dividends

What sector is Nurix Therapeutics in?

Nurix Therapeutics is in the Healthcare sector

What industry is Nurix Therapeutics in?

Nurix Therapeutics is in the Biotechnology industry

What country is Nurix Therapeutics based in?

Nurix Therapeutics is headquartered in United States

When did Nurix Therapeutics go public?

Nurix Therapeutics's initial public offering (IPO) was on July 24, 2020

Is Nurix Therapeutics in the S&P 500?

No, Nurix Therapeutics is not included in the S&P 500 index

Is Nurix Therapeutics in the NASDAQ 100?

No, Nurix Therapeutics is not included in the NASDAQ 100 index

Is Nurix Therapeutics in the Dow Jones?

No, Nurix Therapeutics is not included in the Dow Jones index

When was Nurix Therapeutics's last earnings report?

Nurix Therapeutics's most recent earnings report was on Jan 28, 2025

When does Nurix Therapeutics report earnings?

The next expected earnings date for Nurix Therapeutics is Apr 10, 2025

Should I buy Nurix Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page